About Neupulse
Neupulse is a Healthcare company based in Nottingham (United Kingdom) founded in 2021. It develops wearable devices and apps to manage Tourette Syndrome tics and urges. It operates on a D2C model. Neupulse has raised $4.95 million across 3 funding rounds from investors including Midlands Engine and Eos. Neupulse offers products and services including Wearable Wrist Device and Neutrack App. Its focus areas include Neurotech, Neurological Disorders and Tic Management. Its legal entity is NEUROTHERAPEUTICS LTD.
Company details
Neupulse, based in Nottingham, England, focuses on creating innovative non-drug treatments for Tourette Syndrome. They develop a wearable wrist device that uses gentle median nerve stimulation to reduce tics and urges. The company also works on a mobile app for symptom monitoring and conducts clinical trials with participants in the UK. Collaborating with healthcare organizations, they aim to provide accessible options for symptom management through research and device sales.
- Headquarters Nottingham, United Kingdom
- SectorsHealthcare
- Email••••••••
- Website neupulse.co.uk
- Social Facebook Instagram
- Legal Name Neurotherapeutics Ltd
- Date of Incorporation 12 Feb, 2021
- Jurisdiction NOTTINGHAM, ENGLAND
- Total Equity Funding$4.95M (USD)
in 3 rounds
- Latest Funding Round$642.15K (USD), Seed
Jul 2024
- InvestorsMidlands Engine
& 1 more
Products & Services of Neupulse
Neupulse offers a comprehensive portfolio of products and services, including Wearable Wrist Device and Neutrack App.
Delivers electrical pulses to reduce tics in Tourette Syndrome patients.
Monitors Tourette Syndrome symptoms and external factors over time.
Funding Insights of Neupulse
Neupulse has successfully raised a total of $4.95M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $642.15 thousand completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.95M
- Total Rounds 3
- Last Round Seed — $642,150
- First Round $1.1M
(Jan 2023)
- Investors Count 2
All 3 funding rounds of Neupulse with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $642,150 | Seed | – | Midlandsengine | – |
| Mar 2024 | $3.2M | Seed | – | Eos Advisory | – |
| Jan 2023 | $1.1M | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Neupulse
Neupulse has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Midlands Engine and Eos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in science and technology is managed by Eos. | 2014 | eos-advisory.com | St Andrews, Scotland | |
A regional partnership focused on economic growth in the Midlands. | 2015 | midlandsengine.org | United Kingdom |
Investor details for Neupulse
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Neupulse
4 people are tracked at Neupulse (3 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Barbara Morera | Chief Research Officer | Leadership |
Paul Cable | Chief Executive Officer | Leadership |
David Moser | Chief Technology Officer | Leadership |
Kyran Latham | Office Manager | Team |
Complete people profiles for Neupulse
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Neupulse
3 dated milestones of Neupulse across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Neupulse is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Seed, of $642K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neupulse
Complete news archive for Neupulse
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neupulse
Neupulse was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Neupulse is headquartered in Nottingham, United Kingdom.
Neupulse is a funded company, having raised a total of $4.95M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.1M, raised on Jan 2023.
Neupulse, based in Nottingham, England, focuses on creating innovative non-drug treatments for Tourette Syndrome. They develop a wearable wrist device that uses gentle median nerve stimulation to reduce tics and urges. The company also works on a mobile app for symptom monitoring and conducts clinical trials with participants in the UK. Collaborating with healthcare organizations, they aim to provide accessible options for symptom management through research and device sales.
Neupulse offers Wearable Wrist Device and Neutrack App.
Neupulse has 2 investors. Key investors include Midlands Engine, and Eos.
Neupulse operates through Neurotherapeutics Ltd.